4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-294547
Options or other derivatives
- Director acquired 32,341 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kiselak Tomas Director | 2026-07-01 | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | I | ||
Loading xslF345X06/ownership.xml…